Menopause is often described in terms of hot flashes, sleep disruption and changes in hormone levels. But researchers are increasingly interested in what happens to the brain during this transition—and whether its effects can be detected years before dementia becomes a concern.
A new study published in Nature Medicine found that 16 blood proteins associated with brain health changed during menopause. The proteins were linked to inflammation, neuronal and synaptic function, metabolism and biological processes connected with Alzheimer’s disease. In older women, higher levels of these proteins were associated with poorer memory and thinking skills and with greater dementia risk.
The findings do not mean that menopause causes dementia in most women. Rather, they offer clues about how hormonal changes during midlife may interact with brain health and why some women may be more vulnerable than others.
A closer look at the transition
Researchers studied 80 women aged 43 to 58 who were premenopausal, perimenopausal or in early postmenopause and were not using hormone therapy for menopause symptoms. Using blood tests that measured more than 100 brain-related molecules, they identified 16 proteins whose levels shifted across the menopause transition.
Inflammatory proteins tended to rise as estradiol, a form of estrogen, declined. Proteins associated with Alzheimer’s-related biology rose as follicle-stimulating hormone, or FSH, increased. FSH rises as ovarian hormone production falls.
The study also found that women who reported night sweats had particularly high levels of inflammatory signalling proteins. This does not prove that night sweats themselves damage the brain, but it suggests that vasomotor symptoms may be connected with broader inflammatory changes during the transition.
Why the brain is involved
Menopause is usually associated with the ovaries, which stop producing estrogen and progesterone. But the brain also contains hormone receptors and plays a role in the transition. As sex hormones decline, FSH rises, and specialized neurons in the hypothalamus contribute to hot flashes and night sweats.
These symptoms can occur alongside sleep problems, mood changes and cognitive difficulties often described as “brain fog.” Previous research has also linked severe or frequent vasomotor symptoms with white matter hyperintensities—brain lesions associated with dementia and stroke—and with markers of Alzheimer’s pathology.
Earlier menopause, whether spontaneous or caused by surgical removal of the ovaries, has been associated with a higher risk of Alzheimer’s disease. However, separating the effects of menopause from aging itself is difficult because aging is the strongest risk factor for dementia.
What the findings could mean
The researchers also examined existing health data from about 12,000 women in their 60s and early 70s. They found that many of the same proteins elevated during menopause were higher among women who had developed cognitive decline or dementia.
This does not establish that the proteins cause dementia, nor does it show that measuring them in midlife can predict an individual woman’s future risk. Blood protein levels can fluctuate, and the menopause group in the new study was small. Larger and longer studies are needed to determine whether these protein patterns are reliable markers of brain health.
Still, the work points to midlife as a potentially important period for prevention. Researchers are planning longer studies to follow women through perimenopause and beyond, combining brain imaging, cognitive testing and blood biomarkers. One goal is to understand why some women experience more cognitive symptoms than others and which biological pathways may be involved.
Source: Science
